Cytogenetic evaluation of two nitroimidazole derivatives

5-Nitroimidazoles are a well-established group of antiprotozoal and antibacterial agents. Thanks to their antimicrobial activity these chemotherapeutic agents inhibit the growth of both anaerobic bacteria and certain anaerobic protozoa such as Trichomonas vaginalis, Entamoeba histolytica and Giardia...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Palermo, Ana María, Mudry, Marta Dolores
Publicado: 2003
Materias:
Acceso en línea:https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_08872333_v17_n1_p35_LopezNigro
http://hdl.handle.net/20.500.12110/paper_08872333_v17_n1_p35_LopezNigro
Aporte de:
id paper:paper_08872333_v17_n1_p35_LopezNigro
record_format dspace
spelling paper:paper_08872333_v17_n1_p35_LopezNigro2023-06-08T15:46:44Z Cytogenetic evaluation of two nitroimidazole derivatives Palermo, Ana María Mudry, Marta Dolores Biomarkers Cytogenetics Genetic toxicology Metronidazole Ornidazole metronidazole nitroimidazole derivative ornidazol richet ornidazole adult analysis of variance article cell culture cell division chemical analysis chromosome aberration chromosome analysis clinical trial controlled clinical trial controlled study cytogenetics female genotoxicity human human cell lymphocyte male mitosis normal human risk assessment sister chromatid exchange Adult Antitrichomonal Agents Cell Culture Techniques Cell Division Chromosome Aberrations DNA Damage Dose-Response Relationship, Drug Female Humans Lymphocytes Male Metronidazole Mitosis Mutagenicity Tests Ornidazole Risk Assessment Sister Chromatid Exchange Entamoeba histolytica Giardia intestinalis Protozoa Trichomonas vaginalis 5-Nitroimidazoles are a well-established group of antiprotozoal and antibacterial agents. Thanks to their antimicrobial activity these chemotherapeutic agents inhibit the growth of both anaerobic bacteria and certain anaerobic protozoa such as Trichomonas vaginalis, Entamoeba histolytica and Giardia lamblia. The aim of the present study is to achieve a precise characterization of the genotoxic activity of these compounds and to establish the value of cytogenetic assays in order to determine the effect of these drugs, at therapeutic doses, to settle an improved risk assessment. Two nitroimidazole were studied, metronidazole and ornidazole, at four different concentrations (0.1, 1, 10 and 50 μg/ml of peripheral blood lymphocyte culture). Endpoints analyzed included: mitotic index (MI), replication index (RI), sister chromatid exchange (SCE) and chromosomal aberrations (CA). An analysis of variance test (ANOVA) was performed to evaluate the results. A significant decrease (P<0.0001) in MI as well as an increase in SCE (P<0.0001) and CA (0.0001) frequencies for both drugs was observed. No modifications in RI were found. The results suggest a genotoxic and cytotoxic effect of MTZ and ONZ in human peripheral blood cultures in vitro. © 2002 Elsevier Science Ltd. All rights reserved. Fil:Palermo, A.M. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. Fil:Mudry, M.D. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina. 2003 https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_08872333_v17_n1_p35_LopezNigro http://hdl.handle.net/20.500.12110/paper_08872333_v17_n1_p35_LopezNigro
institution Universidad de Buenos Aires
institution_str I-28
repository_str R-134
collection Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA)
topic Biomarkers
Cytogenetics
Genetic toxicology
Metronidazole
Ornidazole
metronidazole
nitroimidazole derivative
ornidazol richet
ornidazole
adult
analysis of variance
article
cell culture
cell division
chemical analysis
chromosome aberration
chromosome analysis
clinical trial
controlled clinical trial
controlled study
cytogenetics
female
genotoxicity
human
human cell
lymphocyte
male
mitosis
normal human
risk assessment
sister chromatid exchange
Adult
Antitrichomonal Agents
Cell Culture Techniques
Cell Division
Chromosome Aberrations
DNA Damage
Dose-Response Relationship, Drug
Female
Humans
Lymphocytes
Male
Metronidazole
Mitosis
Mutagenicity Tests
Ornidazole
Risk Assessment
Sister Chromatid Exchange
Entamoeba histolytica
Giardia intestinalis
Protozoa
Trichomonas vaginalis
spellingShingle Biomarkers
Cytogenetics
Genetic toxicology
Metronidazole
Ornidazole
metronidazole
nitroimidazole derivative
ornidazol richet
ornidazole
adult
analysis of variance
article
cell culture
cell division
chemical analysis
chromosome aberration
chromosome analysis
clinical trial
controlled clinical trial
controlled study
cytogenetics
female
genotoxicity
human
human cell
lymphocyte
male
mitosis
normal human
risk assessment
sister chromatid exchange
Adult
Antitrichomonal Agents
Cell Culture Techniques
Cell Division
Chromosome Aberrations
DNA Damage
Dose-Response Relationship, Drug
Female
Humans
Lymphocytes
Male
Metronidazole
Mitosis
Mutagenicity Tests
Ornidazole
Risk Assessment
Sister Chromatid Exchange
Entamoeba histolytica
Giardia intestinalis
Protozoa
Trichomonas vaginalis
Palermo, Ana María
Mudry, Marta Dolores
Cytogenetic evaluation of two nitroimidazole derivatives
topic_facet Biomarkers
Cytogenetics
Genetic toxicology
Metronidazole
Ornidazole
metronidazole
nitroimidazole derivative
ornidazol richet
ornidazole
adult
analysis of variance
article
cell culture
cell division
chemical analysis
chromosome aberration
chromosome analysis
clinical trial
controlled clinical trial
controlled study
cytogenetics
female
genotoxicity
human
human cell
lymphocyte
male
mitosis
normal human
risk assessment
sister chromatid exchange
Adult
Antitrichomonal Agents
Cell Culture Techniques
Cell Division
Chromosome Aberrations
DNA Damage
Dose-Response Relationship, Drug
Female
Humans
Lymphocytes
Male
Metronidazole
Mitosis
Mutagenicity Tests
Ornidazole
Risk Assessment
Sister Chromatid Exchange
Entamoeba histolytica
Giardia intestinalis
Protozoa
Trichomonas vaginalis
description 5-Nitroimidazoles are a well-established group of antiprotozoal and antibacterial agents. Thanks to their antimicrobial activity these chemotherapeutic agents inhibit the growth of both anaerobic bacteria and certain anaerobic protozoa such as Trichomonas vaginalis, Entamoeba histolytica and Giardia lamblia. The aim of the present study is to achieve a precise characterization of the genotoxic activity of these compounds and to establish the value of cytogenetic assays in order to determine the effect of these drugs, at therapeutic doses, to settle an improved risk assessment. Two nitroimidazole were studied, metronidazole and ornidazole, at four different concentrations (0.1, 1, 10 and 50 μg/ml of peripheral blood lymphocyte culture). Endpoints analyzed included: mitotic index (MI), replication index (RI), sister chromatid exchange (SCE) and chromosomal aberrations (CA). An analysis of variance test (ANOVA) was performed to evaluate the results. A significant decrease (P<0.0001) in MI as well as an increase in SCE (P<0.0001) and CA (0.0001) frequencies for both drugs was observed. No modifications in RI were found. The results suggest a genotoxic and cytotoxic effect of MTZ and ONZ in human peripheral blood cultures in vitro. © 2002 Elsevier Science Ltd. All rights reserved.
author Palermo, Ana María
Mudry, Marta Dolores
author_facet Palermo, Ana María
Mudry, Marta Dolores
author_sort Palermo, Ana María
title Cytogenetic evaluation of two nitroimidazole derivatives
title_short Cytogenetic evaluation of two nitroimidazole derivatives
title_full Cytogenetic evaluation of two nitroimidazole derivatives
title_fullStr Cytogenetic evaluation of two nitroimidazole derivatives
title_full_unstemmed Cytogenetic evaluation of two nitroimidazole derivatives
title_sort cytogenetic evaluation of two nitroimidazole derivatives
publishDate 2003
url https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_08872333_v17_n1_p35_LopezNigro
http://hdl.handle.net/20.500.12110/paper_08872333_v17_n1_p35_LopezNigro
work_keys_str_mv AT palermoanamaria cytogeneticevaluationoftwonitroimidazolederivatives
AT mudrymartadolores cytogeneticevaluationoftwonitroimidazolederivatives
_version_ 1768546681033326592